Guggenheim Capital’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.12M Buy
9,282
+2,548
+38% +$571K 0.02% 683
2025
Q4
$1.44M Buy
6,734
+1,428
+27% +$295K 0.01% 776
2025
Q3
$1.05M Sell
5,306
-929
-15% -$173K 0.01% 902
2025
Q2
$1.08M Sell
6,235
-819
-12% -$133K 0.01% 865
2025
Q1
$1.1M Sell
7,054
-195
-3% -$27.9K 0.01% 846
2024
Q4
$998K Buy
7,249
+5,218
+257% +$686K 0.01% 922
2024
Q3
$303K Buy
2,031
+217
+12% +$29.3K ﹤0.01% 1611
2024
Q2
$247K Buy
+1,814
New +$247K ﹤0.01% 1704
2022
Q4
Sell
-2,571
Closed -$265K 1915
2022
Q3
$265K Buy
+2,571
New +$244K ﹤0.01% 1704
2022
Q2
Sell
-2,008
Closed -$236K 2050
2022
Q1
$236K Buy
2,008
+135
+7% +$15.6K ﹤0.01% 1981
2021
Q4
$252K Buy
1,873
+562
+43% +$83.6K ﹤0.01% 1951
2021
Q3
$209K Buy
+1,311
New +$179K ﹤0.01% 2050

Other funds holding ASND